RS35246381 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| 5-acetylamino-6-amino-3-methyluracil levels | T | OR: 0.48 | 1E-352 | PubMed |
| N-acetylputrescine levels | T | OR: 0.66 | 1E-230 | PubMed |
| Urine 5-acetylamino-6-formylamino-3-methyluracil levels in chronic kidney disease | T | OR: 1.15 | 5E-223 | PubMed |
| Urinary metabolites | C | OR: 1.13 | 3E-202 | PubMed |
| Plasma N-acetylputrescine levels in chronic kidney disease | T | OR: 0.25 | 5E-136 | PubMed |
| Serum metabolite levels | C | OR: 0.55 | 7E-128 | PubMed |
| 4-acetamidobutanoate levels | T | OR: 0.48 | 4E-116 | PubMed |
| Triglyceride levels | — | — | 3E-109 | PubMed |
| Urine N-acetylputrescine levels in chronic kidney disease | T | OR: 0.25 | 5E-97 | PubMed |
| Metabolite levels (4-acetamidobutanoate) | T | OR: 0.29 | 3E-84 | PubMed |
| Plasma 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney disease | T | OR: 0.58 | 7E-69 | PubMed |
| Triglycerides in large HDL | T | β: 0.04 | 2E-63 | PubMed |
| Triglyceride levels | T | β: 0.034 | 3E-63 | PubMed |
| Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney disease | T | OR: 0.51 | 5E-62 | PubMed |
| Cholesteryl Esters to Total Lipids in Small HDL percentage | T | β: 0.03 | 2E-48 | PubMed |
| Free Cholesterol to Total Lipids in IDL percentage | T | β: 0.03 | 8E-44 | PubMed |
| Triglyceride levels (MTAG) | T | β: 0.041 | 1E-42 | PubMed |
| Phospholipids to Total Lipids in Small VLDL percentage | T | β: 0.03 | 1E-31 | PubMed |
| Free Cholesterol to Total Lipids in Small VLDL percentage | T | β: 0.03 | 2E-29 | PubMed |
| Urinary metabolite modules (eigenmetabolites) in chronic kidney disease | C | β: 0.01 | 2E-25 | PubMed |